Welcome to Valicare!

ACHEMA - WORLD FORUM AND 34th LEADING INTERNATIONAL TRADE FAIR, JUNE 10th-14th, 2024

This year, a team of Valicare experts will also be present at Achema. You are welcome to visit us at this fascinating event. Further details and information on the registration form can be found here. >>>

APV SEMINAR, MAY 14th-15th, 2024

The seminar will cover biopharma stability and cold stability for biologics/therapeutic proteins, with topics such as mechanisms of freezing, control of freezing & thawing, modelling, equipment, stabilisation by excipients, R&D strategies and alternative methods.

Further information and the registration form can be found here. >>>

CHAMPALIMAUD FOUNDATION:TIL-WORKSHOP, APRIL 24th-25th, 2024

Visit the Champalimaud TIL workshop (Tumor Infiltrating Lymphocytes) for the treatment of patients with solid cancers. For more information click here >>>

ATMP BLOCK LECTURE, APRIL 12th, 2024

vOnline introduction to the pharmaceutical requirements for the manufacture and testing of ATMPs. Register in good time, there are only 30 external places available. Click here to register >>>

GMP PHARMA CONGRESS, MARCH 20th, 2024

As a part of the GMP Pharma Congress, you can look forward to an exciting presentation by our Senior GMP Project Manager Dr Carsten Börger in collaboration with Frank Hesseler from Schlafender Hase. The topic of the presentation is the ,,Development and validation of a cloud-based system for automated text verification''. Information and registration form can be found here. >>>

DG-GT ANNUAL MEETING, MARCH 6th-8th, 2024

The DG-GT e.V. brings together scientists and clinicians who are involved in the most diverse areas of vector development, gene transfer techniques, gene therapy treatment strategies and their implementation in the clinic. More information can be found here >>>

CULT.TAINER WEB SESSION, JANUARY 30th, 2024

In this webinar, we will introduce the cult.tainer® concept, a turnkey production solution for GMP-compliant iATMPs. For further details and the registration formular, click here. >>>

VIRTUAL LECTURES GMP-BASICS I-III, NOVEMBER 3 & 4 & 24, 2023

The lecture by Dr. Hans-Georg Eckert, Managing Director and Senior Consultant of Valicare GmbH, will take place as part of the Master's Course MSc Bioanalytical Chemistry and Pharmaceutical Analysis at Fresenius University in Idstein. The three virtual training modules will be offered free of charge via Zoom. For further details and the access link, please click here. >>>

ISPE-ATMP SEMINAR, NOVEMBER 20 & 21, 2023

An ISPE DACH ATMP seminar focusing on aseptic processing technologies in the pharmaceutical industry. The event will include a tour of the Robert Bosch Hospital. More details about the event can be found on the linked website. >>>

7TH CELL THERAPY SYMPOSIUM, NOVEMBER 3 & 4, 2023

We are excited to be part of this year's 6th Cell Therapy Symposium at Heidelberg University Hospital. This symposium serves as a platform for the latest advancements in cell therapy.
>>>

08th of December 2023: FDA approves Casgevy

The success story of CRISPR/Cas9 continues: The FDA approved Casgevy in the USA on December 8th 2023. This makes Casgevy the first FDA-approved therapy to use CRISPR/Cas9. This is a major step forward in the field of ATMPs. We are eager to see how the success story continues. >>>

05th of December 2023: The first CRISPR/Cas9-based therapy has reached the market

The admission of Casgevy (Exagamglogene autotemcel) opens a new chapter in CRISPR/Cas9-based gene therapy and ATMP manufacture. >>>

10th of November 2023: Successfully transferring ATMPs to patients and market

With the "cult.tainer®", Valicare offers a turnkey production concept for the GMP-compliant manufacturer of iATMPs/ATMPs. Further information also about the free cult.tainer® web session on 5th, 2023 and access further information here. >>>

22th of August 2023: Prohibition of PFAS – Evaluate, assess risks, time to act

In the last years the restrictions of PFAS increased rapidly. Since early 2023 a complete prohibition of PFAS is discussed.

>>>

2th of August 2023: Revision of Annex 1

New approaches are required soon! A challenge for your company? Get an overview about the most important upcoming changes

>>>

13th of June 2023: ATMPs are high potentials in the treatment of previously incurable diseases

Their production remains a challenge. Read here how to coordinate planning, construction of the production plant and implementation of the production processes in parallel and efficiently.

>>>